◀ Back to AGTR2
AGTR2 — EDN1
Pathways - manually collected, often from reviews:
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
G-protein receptor/G-gamma/G-beta/G-alpha-S/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNGT1-GNB1-GNAS)
→
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
(modification, collaborate)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
G-protein receptor/G-gamma/G-beta/G-alpha-S/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNGT1-GNB1-GNAS)
→
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
(modification, collaborate)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
G-alpha-s/GTP complex (GNAS)
→
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
(modification, collaborate)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
→
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
(modification, collaborate)
-
BioCarta chrebp regulation by carbohydrates and camp:
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
GPCR/g-alpha-s/g-beta/g-gamma/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNAS-GNGT1-GNB1)
(modification, collaborate)
-
BioCarta chrebp regulation by carbohydrates and camp:
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
GTP/G-alpha-S complex (GNAS)
(modification, collaborate)
-
BioCarta chrebp regulation by carbohydrates and camp:
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
(modification, collaborate)
-
BioCarta chrebp regulation by carbohydrates and camp:
GPCR/g-alpha-s/g-beta/g-gamma/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNAS-GNGT1-GNB1)
→
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
(modification, collaborate)
-
BioCarta ß-arrestins in gpcr desensitization:
ligand/GPCR complex (CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3)
→
G-protein Receptor (HTR2C/ADRA1B/AGTR2/CHRM1/CCR5/PTGER1/P2RY2/CCR3/EDNRB/EDNRA/CXCR4/FPR1/ADRB2)
(degradation, collaborate)
-
BioCarta activation of camp-dependent protein kinase pka:
G-protein receptor/G-gamma/G-beta/G-alpha-S/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNGT1-GNB1-GNAS)
→
G-protein receptor/G-gamma/G-beta/Ligand complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNGT1-GNB1-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3)
(modification, collaborate)
-
BioCarta activation of camp-dependent protein kinase pka:
G-protein receptor/G-gamma/G-beta/G-alpha-S/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNGT1-GNB1-GNAS)
→
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
(modification, collaborate)
-
BioCarta activation of camp-dependent protein kinase pka:
G-alpha-s/GTP complex (GNAS)
→
G-protein receptor/G-gamma/G-beta/Ligand complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNGT1-GNB1-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3)
(modification, collaborate)
-
BioCarta activation of camp-dependent protein kinase pka:
G-protein receptor/G-gamma/G-beta/Ligand complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNGT1-GNB1-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3)
→
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
(modification, collaborate)
-
BioCarta roles of ß arrestin dependent recruitment of src kinases in gpcr signaling:
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
GPCR/g-alpha-s/g-beta/g-gamma/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNAS-GNGT1-GNB1)
(modification, collaborate)
-
BioCarta roles of ß arrestin dependent recruitment of src kinases in gpcr signaling:
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
G-alpha-s/GTP complex (GNAS)
(modification, collaborate)
-
BioCarta roles of ß arrestin dependent recruitment of src kinases in gpcr signaling:
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
(modification, collaborate)
-
BioCarta roles of ß arrestin dependent recruitment of src kinases in gpcr signaling:
GPCR/g-alpha-s/g-beta/g-gamma/GDP complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-GNAS-GNGT1-GNB1)
→
Ligand (CCL4/EDN1//AGT/CCL11/CXCL12/F2)
(modification, collaborate)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
atp:[beta-adrenergic-receptor] phosphotransferase (ADRBK1)
→
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
(modification, activates)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
atp:[beta-adrenergic-receptor] phosphotransferase (ADRBK1)
→
Ligand/GPCR(+)/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
(modification, activates)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
Ligand/GPCR/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
Ligand/GPCR(+)/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
(modification, collaborate)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
g-gamma/g-beta complex (GNGT1-GNB1)
→
Ligand/GPCR(+)/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
(modification, collaborate)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
Ligand/GPCR(+)/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
Ligand/GPCR(+)/Arrestin complex (CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-ARRB1)
(modification, collaborate)
-
BioCarta role of ß-arrestins in the activation and targeting of map kinases:
Ligand/GPCR(+)/g-beta/g-gamma complex (HTR2C_ADRA1B_AGTR2_CHRM1_CCR5_PTGER1_P2RY2_CCR3_CXCR4_FPR1_ADRB2-CCL4_EDN1__AGT_CCL11_CXCL12_F2_compound:CAS66575-29-9_compound:CAS745-65-3-GNGT1-GNB1)
→
Arrestin (ARRB1)
(modification, collaborate)
Text-mined interactions from Literome
Luo et al., Sheng Li Xue Bao 1999
:
The
effects of
endothelin-1 (ET-1) on pulmonary surfactant ( PS ) synthesis of cultured
alveolar type II cells (AT II) were observed
Ohanian et al., Arterioscler Thromb Vasc Biol 2001
:
In contrast,
endothelin induced a biphasic response, with activation
at 2 and 10 minutes
Lakó-Futó et al., Circulation 2003
(Cardiomyopathy, Hypertrophic...) :
In contrast,
AT2-R blockade
resulted in a marked increase in the gene expression of c-fos,
endothelin-1 , and insulin-like growth factor-1 in Ang II-induced hypertension ... In contrast,
AT2-R blockade
resulted in a marked increase in the gene expression of c-fos,
endothelin-1 , and insulin-like growth factor-1 in Ang II-induced hypertension
Lerch et al., J Cardiovasc Pharmacol 1998
(Genetic Predisposition to Disease...) :
Effects of
angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and
endothelin in normotensive offspring of hypertensive parents